API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214512
https://www.prnewswire.com/news-releases/new-data-from-amgens-prolia-denosumab-demonstrates-significant-reduction-in-osteoporotic-fracture-risk-compared-to-alendronate-301818134.html
https://news.bloomberglaw.com/health-law-and-business/merck-beats-suits-tying-thighbone-fractures-to-osteoporosis-drug?context=search&index=17
https://www.fiercepharma.com/pharma/supreme-court-sends-merck-fosamax-cases-back-to-appeals-court
https://www.yahoo.com/news/u-supreme-court-tosses-ruling-against-merck-fosamax-142540142--finance.html
https://endpts.com/amgen-prices-bone-builder-evenity-at-21900-year-to-compete-on-convenience-not-cost/
https://endpts.com/once-spurned-amgen-wins-the-fda-over-with-its-bone-building-osteoporosis-drug-evenity/
https://www.druganddevicelawblog.com/2019/03/the-ripples-of-the-fosamax-reversal.html
https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/UCM293268.pdf
https://www.reuters.com/article/us-usa-court-merck-co/u-s-supreme-court-could-side-with-merck-over-fosamax-lawsuits-idUSKCN1P11OX
https://www.statnews.com/2019/01/03/supreme-court-examine-legal-strategy-sidestep-patient-lawsuits/?utm_source=STAT+Newsletters&utm_campaign=e90a32c8a7-Readout_COPY_03&utm_medium=email&utm_term=0_8cab1d7961-e90a32c8a7-151110593
https://www.pharmacompass.com/pdf/news/List-of-New-Paragraph-IV-Certifications-as-of-Aug-21-2018-1534919998.pdf
https://www.reuters.com/article/us-usa-court-merck-co/u-s-supreme-court-to-hear-merck-appeal-over-fosamax-suits-idUSKBN1JO1Y7
https://www.fiercepharma.com/pharma/merck-rebuts-petition-urging-scotus-to-ignore-fosamax-appeal
https://www.fiercepharma.com/legal/scotus-petition-merck-argues-pharma-cases-are-especially-important-to-get-right
https://www.druganddevicelawblog.com/2017/10/the-third-circuit-fosamax-preemption-error-has-got-to-go-part-2.html
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0735-2016&w=03092016&lang=eng
http://www.fiercepharmamarketing.com/story/can-sprouts-addyi-shrug-serious-side-effects-these-blockbusters-did/2015-08-26
http://www.alternet.org/personal-health/8-invented-diseases-big-pharma-banking
http://blogs.wsj.com/pharmalot/2015/01/23/ema-recommends-hundreds-of-drugs-to-be-suspended-over-flawed-studies/
http://blogs.wsj.com/pharmalot/2015/01/21/supreme-court-declines-to-review-case-about-generic-labeling/